Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy A Nixon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|July 25, 2022
Triple-Negative Breast Cancer: A Review of Current Curative Intent TherapiesIsaiah MacDonald, Nancy A Nixon, Omar F Khan
BMJ Case Reports|January 29, 2021
Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapyMehrnoosh Pauls, Natalia Rydz, Nancy A Nixon, et al.
The Breast Journal|September 4, 2019
Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting PartnershipNancy A Nixon, Christine Simmons, Julie Lemieux, et al.
BMJ Case Reports|February 15, 2017
Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancerDaniel Meyers, Nancy A Nixon, Angela Franko, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in CanadaDoreen A Ezeife, Veronica Kirk, Derek S Chew, et al.
Cancer Treatment and Research Communications|June 6, 2021
Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancerAtul Batra, Nancy A Nixon, Gloria Roldan-Urgoiti, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
The Canadian Breast Cancer Symposium 2025: Meeting ReportChristine Brezden-Masley, Katarzyna J Jerzak, Nancy A Nixon, et al.
Cancer|August 18, 2017
Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014Nancy A Nixon, Omar F Khan, Hasiba Imam, et al.
Breast (Edinburgh, Scotland)|April 26, 2021
A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropeniaMark Clemons, Dean Fergusson, Anil A Joy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|July 25, 2022
Triple-Negative Breast Cancer: A Review of Current Curative Intent TherapiesIsaiah MacDonald, Nancy A Nixon, Omar F Khan
BMJ Case Reports|January 29, 2021
Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapyMehrnoosh Pauls, Natalia Rydz, Nancy A Nixon, et al.
The Breast Journal|September 4, 2019
Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting PartnershipNancy A Nixon, Christine Simmons, Julie Lemieux, et al.
BMJ Case Reports|February 15, 2017
Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancerDaniel Meyers, Nancy A Nixon, Angela Franko, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in CanadaDoreen A Ezeife, Veronica Kirk, Derek S Chew, et al.
Cancer Treatment and Research Communications|June 6, 2021
Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancerAtul Batra, Nancy A Nixon, Gloria Roldan-Urgoiti, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
The Canadian Breast Cancer Symposium 2025: Meeting ReportChristine Brezden-Masley, Katarzyna J Jerzak, Nancy A Nixon, et al.
Cancer|August 18, 2017
Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014Nancy A Nixon, Omar F Khan, Hasiba Imam, et al.
Breast (Edinburgh, Scotland)|April 26, 2021
A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropeniaMark Clemons, Dean Fergusson, Anil A Joy, et al.
Pageof 1